GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options, underscoring the need for novel therapeutic targets. Metabolic reprogramming is a hallmark of PDAC, enabling tumor cells to sustain rapid proliferation and survive under nutrient-deprived conditions. Whil...

Full description

Saved in:
Bibliographic Details
Main Authors: Jenna N. Duttenhefner, Katie M. Reindl
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Molecular & Cellular Oncology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/23723556.2025.2518773
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334644488536064
author Jenna N. Duttenhefner
Katie M. Reindl
author_facet Jenna N. Duttenhefner
Katie M. Reindl
author_sort Jenna N. Duttenhefner
collection DOAJ
description Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options, underscoring the need for novel therapeutic targets. Metabolic reprogramming is a hallmark of PDAC, enabling tumor cells to sustain rapid proliferation and survive under nutrient-deprived conditions. While glutathione S-transferase pi 1 (GSTP1) is a known regulator of redox homeostasis in PDAC, its role in metabolic adaptation remains unclear. Here, we show that GSTP1 knockdown disrupts PDAC metabolism, leading to downregulation of key metabolic enzymes (ALDH7A1, CPT1A, SLC2A3, PGM1), ATP depletion, mitochondrial dysfunction, and phospholipid remodeling. Phospholipid remodeling, including an increase in phosphatidylcholine (PC) levels, further suggests a compensatory response to metabolic stress. Importantly, GSTP1 knockdown led to elevated lipid peroxidation, increasing 4-hydroxynonenal (4-HNE) accumulation. Treatment with the antioxidant N-acetyl cysteine (NAC) partially restored metabolic gene expression, reinforcing GSTP1’s role in the interplay between redox regulation and metabolism in PDAC. By disrupting multiple metabolic pathways, GSTP1 depletion creates potential therapeutic vulnerabilities that could be targeted through metabolic and oxidative stress-inducing therapies to enhance treatment efficacy.
format Article
id doaj-art-ccca6a6575e44c43abb3a56cf59c5ae9
institution Kabale University
issn 2372-3556
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Molecular & Cellular Oncology
spelling doaj-art-ccca6a6575e44c43abb3a56cf59c5ae92025-08-20T03:45:31ZengTaylor & Francis GroupMolecular & Cellular Oncology2372-35562025-12-0112110.1080/23723556.2025.2518773GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cellsJenna N. Duttenhefner0Katie M. Reindl1Department of Biological Sciences, North Dakota State University, Fargo, ND, USADepartment of Biological Sciences, North Dakota State University, Fargo, ND, USAPancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options, underscoring the need for novel therapeutic targets. Metabolic reprogramming is a hallmark of PDAC, enabling tumor cells to sustain rapid proliferation and survive under nutrient-deprived conditions. While glutathione S-transferase pi 1 (GSTP1) is a known regulator of redox homeostasis in PDAC, its role in metabolic adaptation remains unclear. Here, we show that GSTP1 knockdown disrupts PDAC metabolism, leading to downregulation of key metabolic enzymes (ALDH7A1, CPT1A, SLC2A3, PGM1), ATP depletion, mitochondrial dysfunction, and phospholipid remodeling. Phospholipid remodeling, including an increase in phosphatidylcholine (PC) levels, further suggests a compensatory response to metabolic stress. Importantly, GSTP1 knockdown led to elevated lipid peroxidation, increasing 4-hydroxynonenal (4-HNE) accumulation. Treatment with the antioxidant N-acetyl cysteine (NAC) partially restored metabolic gene expression, reinforcing GSTP1’s role in the interplay between redox regulation and metabolism in PDAC. By disrupting multiple metabolic pathways, GSTP1 depletion creates potential therapeutic vulnerabilities that could be targeted through metabolic and oxidative stress-inducing therapies to enhance treatment efficacy.https://www.tandfonline.com/doi/10.1080/23723556.2025.2518773Pancreatic ductal adenocarcinomaglutathione S-transferase pi 1 (GSTP1)metabolic reprogrammingmetabolomicstherapeutic targeting
spellingShingle Jenna N. Duttenhefner
Katie M. Reindl
GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
Molecular & Cellular Oncology
Pancreatic ductal adenocarcinoma
glutathione S-transferase pi 1 (GSTP1)
metabolic reprogramming
metabolomics
therapeutic targeting
title GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
title_full GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
title_fullStr GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
title_full_unstemmed GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
title_short GSTP1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
title_sort gstp1 knockdown induces metabolic changes affecting energy production and lipid balance in pancreatic cancer cells
topic Pancreatic ductal adenocarcinoma
glutathione S-transferase pi 1 (GSTP1)
metabolic reprogramming
metabolomics
therapeutic targeting
url https://www.tandfonline.com/doi/10.1080/23723556.2025.2518773
work_keys_str_mv AT jennanduttenhefner gstp1knockdowninducesmetabolicchangesaffectingenergyproductionandlipidbalanceinpancreaticcancercells
AT katiemreindl gstp1knockdowninducesmetabolicchangesaffectingenergyproductionandlipidbalanceinpancreaticcancercells